“Efficacy of Secukinumab in Patients With Mild to Moderate Psoriasis: A Pooled Analysis of 6 Phase 3 Studies ”, J of Skin, vol. 7, no. 6, p. s231, Nov. 2023, doi: 10.25251/skin.7.supp.231.